Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial
Top Cited Papers
- 1 November 2002
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 360 (9343) , 1375-1380
- https://doi.org/10.1016/s0140-6736(02)11401-2
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Treatment of Diarrhea Caused byGiardia intestinalisandEntamoeba histolyticaorE. dispar:A Randomized, Double‐Blind, Placebo‐Controlled Study of NitazoxanideThe Journal of Infectious Diseases, 2001
- Practice Guidelines for the Management of Infectious DiarrheaClinical Infectious Diseases, 2001
- Paromomycin: No More Effective than Placebo for Treatment of Cryptosporidiosis in Patients with Advanced Human Immunodeficiency Virus InfectionClinical Infectious Diseases, 2000
- A double-‘blind’ placebo-controlled study of nitazoxanide in the treatment of cryptosporidial diarrhoea in aids patients in MexicoTransactions of the Royal Society of Tropical Medicine and Hygiene, 1998
- Cryptosporidiosis: An Emerging, Highly Infectious ThreatEmerging Infectious Diseases, 1997
- Case management of kwashiorkor: an intervention project at seven nutrition rehabilitation centres in MalawiEuropean Journal of Clinical Nutrition, 1997
- Paromomycin for Cryptosporidiosis in AIDS: A Prospective, Double-Blind TrialThe Journal of Infectious Diseases, 1994
- Cryptosporidiosis in infancy and childhood mortality in Guinea Bissau, west Africa.BMJ, 1993
- Evaluation of New Anti-Infective Drugs for the Treatment of Diarrhea Caused by Giardia lambliaClinical Infectious Diseases, 1992
- Cryptosporidium, chronic diarrhoea and the proximal small intestinal mucosa.Gut, 1992